Optagon Labs CEO Khalil Kaddoura focuses on the experiments needed to optimize a drug candidate before human testing. He outlines a proposed loop of molecular modeling, digital experiments, selected lab tests, and feedback from results. The judges ask how this workflow operates, who uses it, and what the company's validation work includes.
More from the studio
AI x Bio Pitch Contest
A short look at the September 29 AI x Bio Pitch Contest in San Francisco, from company pitches to the award presentations.
Oct 5, 2026
AI x Bio Pitch Contest — Umbra Bio
Paul Donohoue presents Umbra Bio's approach to multi-attribute protein design and answers the judges' questions.
Oct 5, 2026
AI x Bio Pitch Contest — Eigen Bio
Kristin Gleitsman explains how Eigen Bio uses patient samples and an RNA foundation model to explore therapeutic targets.
Oct 5, 2026